The total number record retrieved from this search are 100. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_2014	Reovirus	Reovirus T3D	RNA	Reoviridae	None	Yes	No	No	NA	Human prostate cancer cell line	PC-3	5.0E+3 cells per well	NA	MTS assay	0.1 MOI	70% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2015	Reovirus	Reovirus T3D	RNA	Reoviridae	None	Yes	No	No	NA	Human prostate cancer cell line	PC-3	5.0E+3 cells per well	NA	MTS assay	1 MOI	30% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2016	Reovirus	Reovirus T3D	RNA	Reoviridae	None	Yes	No	No	NA	Human prostate cancer cell line	PC-3	5.0E+3 cells per well	NA	MTS assay	10 MOI	10% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2017	Reovirus	Reovirus T3D	RNA	Reoviridae	None	Yes	No	No	NA	Human prostate cancer cell line	PC-3	5.0E+3 cells per well	NA	MTS assay	100 MOI	100% cell death	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2018	Reovirus	Reovirus T3D	RNA	Reoviridae	None	Yes	No	No	NA	Human prostate cancer cell line	LNCaP	7.5E+3 cells per well	NA	MTS assay	0.1 MOI	90% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2019	Reovirus	Reovirus T3D	RNA	Reoviridae	None	Yes	No	No	NA	Human prostate cancer cell line	LNCaP	7.5E+3 cells per well	NA	MTS assay	1 MOI	60% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2020	Reovirus	Reovirus T3D	RNA	Reoviridae	None	Yes	No	No	NA	Human prostate cancer cell line	LNCaP	7.5E+3 cells per well	NA	MTS assay	10 MOI	20% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2021	Reovirus	Reovirus T3D	RNA	Reoviridae	None	Yes	No	No	NA	Human prostate cancer cell line	LNCaP	7.5E+3 cells per well	NA	MTS assay	100 MOI	100% cell death	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2022	Reovirus	Reovirus T3D	RNA	Reoviridae	None	Yes	No	No	NA	Human prostate cancer cell line	Du145	7.5E+3 cells per well	NA	MTS assay	0.1 MOI	100% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2023	Reovirus	Reovirus T3D	RNA	Reoviridae	None	Yes	No	No	NA	Human prostate cancer cell line	Du145	7.5E+3 cells per well	NA	MTS assay	1 MOI	100% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2024	Reovirus	Reovirus T3D	RNA	Reoviridae	None	Yes	No	No	NA	Human prostate cancer cell line	Du145	7.5E+3 cells per well	NA	MTS assay	10 MOI	70% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2025	Reovirus	Reovirus T3D	RNA	Reoviridae	None	Yes	No	No	NA	Human prostate cancer cell line	Du145	7.5E+3 cells per well	NA	MTS assay	100 MOI	10% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2026	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (7.5 nM)	No	NA	Human prostate cancer cell line	PC-3	5.0E+3 cells per well	NA	MTS assay	0.125 MOI	80% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2027	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (15 nM)	No	NA	Human prostate cancer cell line	PC-3	5.0E+3 cells per well	NA	MTS assay	0.25 MOI	70% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2028	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (30 nM)	No	NA	Human prostate cancer cell line	PC-3	5.0E+3 cells per well	NA	MTS assay	0.5 MOI	60% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2029	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (60 nM)	No	NA	Human prostate cancer cell line	PC-3	5.0E+3 cells per well	NA	MTS assay	1 MOI	50% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2030	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (120 nM)	No	NA	Human prostate cancer cell line	PC-3	5.0E+3 cells per well	NA	MTS assay	2 MOI	40% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2031	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (7.5 nM)	No	NA	Human prostate cancer cell line	LNCaP	7.5E+3 cells per well	NA	MTS assay	0.125 MOI	70% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2032	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (15 nM)	No	NA	Human prostate cancer cell line	LNCaP	7.5E+3 cells per well	NA	MTS assay	0.25 MOI	70% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2033	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (30 nM)	No	NA	Human prostate cancer cell line	LNCaP	7.5E+3 cells per well	NA	MTS assay	0.5 MOI	60% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2034	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (60 nM)	No	NA	Human prostate cancer cell line	LNCaP	7.5E+3 cells per well	NA	MTS assay	1 MOI	50% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2035	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (120 nM)	No	NA	Human prostate cancer cell line	LNCaP	7.5E+3 cells per well	NA	MTS assay	2 MOI	40% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2036	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (120 nM)	No	NA	Human prostate cancer cell line	Du145	7.5E+3 cells per well	NA	MTS assay	0.125 MOI	60% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2037	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (120 nM)	No	NA	Human prostate cancer cell line	Du145	7.5E+3 cells per well	NA	MTS assay	0.25 MOI	45% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2038	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (120 nM)	No	NA	Human prostate cancer cell line	Du145	7.5E+3 cells per well	NA	MTS assay	0.5 MOI	30% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2039	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (120 nM)	No	NA	Human prostate cancer cell line	Du145	7.5E+3 cells per well	NA	MTS assay	1 MOI	20% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2040	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (120 nM)	No	NA	Human prostate cancer cell line	Du145	7.5E+3 cells per well	NA	MTS assay	2 MOI	20% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2041	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	virus in combination with Docetaxel (7.5)	No	NA	Human prostate cancer cell line	Du145	7.5E+3 cells per well		MTS assay	2.15 MOI	70% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2042	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (15 nM)	No	NA	Human prostate cancer cell line	Du145	7.5E+3 cells per well		MTS assay	4.3 MOI	50% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2043	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (30 nM)	No	NA	Human prostate cancer cell line	Du145	7.5E+3 cells per well		MTS assay	8.6 MOI	30% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2044	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (60 nM)	No	NA	Human prostate cancer cell line	Du145	7.5E+3 cells per well		MTS assay	17.2 MOI	10% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2045	Reovirus	Reovirus T3D	RNA	Reoviridae	None	No	Virus strain in combination with Docetaxel (120 nM)	No	NA	Human prostate cancer cell line	Du145	7.5E+3 cells per well		MTS assay	34.4 MOI	10% cell survival	No	No	NA	No response	NA	Virus cause increase in apoptosis	NA	NA	21645351
OV_2253	Herpes simplex virus	Equine Herpesvirus type-1	DNA	Herpesviridae	None	Yes	No	No	NA	Human glioma cell line	Hs683	NA	NA	MTS assay	1 MOI	100% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	22205738
OV_2254	Herpes simplex virus	Equine Herpesvirus type-1	DNA	Herpesviridae	None	Yes	No	No	NA	Human glioma cell line	U251	NA	NA	MTS assay	1 MOI	98% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	22205738
OV_2255	Herpes simplex virus	Equine Herpesvirus type-1	DNA	Herpesviridae	None	Yes	No	No	NA	Human glioma cell line	SNB19	NA	NA	MTS assay	1 MOI	90% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	22205738
OV_2256	Herpes simplex virus	Equine Herpesvirus type-1	DNA	Herpesviridae	None	Yes	No	No	NA	Human glioma cell line	LN-18	NA	NA	MTS assay	1 MOI	60% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	22205738
OV_2257	Herpes simplex virus	Equine Herpesvirus type-1	DNA	Herpesviridae	None	Yes	No	No	NA	Human glioma cell line	A-172	NA	NA	MTS assay	1 MOI	50% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	22205738
OV_2258	Herpes simplex virus	Equine Herpesvirus type-1	DNA	Herpesviridae	None	Yes	No	No	NA	Human glioma cell line	Hs683	NA	NA	MTS assay	3 MOI	100% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	22205738
OV_2259	Herpes simplex virus	Equine Herpesvirus type-1	DNA	Herpesviridae	None	Yes	No	No	NA	Human glioma cell line	U251	NA	NA	MTS assay	3 MOI	90% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	22205738
OV_2260	Herpes simplex virus	Equine Herpesvirus type-1	DNA	Herpesviridae	None	Yes	No	No	NA	Human glioma cell line	SNB19	NA	NA	MTS assay	3 MOI	70% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	22205738
OV_2261	Herpes simplex virus	Equine Herpesvirus type-1	DNA	Herpesviridae	None	Yes	No	No	NA	Human glioma cell line	LN-18	NA	NA	MTS assay	3 MOI	40% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	22205738
OV_2262	Herpes simplex virus	Equine Herpesvirus type-1	DNA	Herpesviridae	None	Yes	No	No	NA	Human glioma cell line	A-172	NA	NA	MTS assay	3 MOI	38% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	22205738
OV_2263	Herpes simplex virus	Equine Herpesvirus type-1	DNA	Herpesviridae	None	Yes	No	No	NA	Human glioma cell line	Hs683	NA	NA	MTS assay	10 MOI	100% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	22205738
OV_2264	Herpes simplex virus	Equine Herpesvirus type-1	DNA	Herpesviridae	None	Yes	No	No	NA	Human glioma cell line	U251	NA	NA	MTS assay	10 MOI	80% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	22205738
OV_2265	Herpes simplex virus	Equine Herpesvirus type-1	DNA	Herpesviridae	None	Yes	No	No	NA	Human glioma cell line	SNB19	NA	NA	MTS assay	10 MOI	60% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	22205738
OV_2266	Herpes simplex virus	Equine Herpesvirus type-1	DNA	Herpesviridae	None	Yes	No	No	NA	Human glioma cell line	LN-18	NA	NA	MTS assay	10 MOI	30% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	22205738
OV_2267	Herpes simplex virus	Equine Herpesvirus type-1	DNA	Herpesviridae	None	Yes	No	No	NA	Human glioma cell line	A-172	NA	NA	MTS assay	10 MOI	30% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	22205738
OV_3464	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	A549	1.0E+5 cells per well	NA	MTS assay	100 MOI	22% inhibition in tumor inhibition	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3465	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	A549-DDPR cisplatin resistant	1.0E+5 cells per well	NA	MTS assay	100 MOI	55% inhibition in tumor inhibition	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3466	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H292	1.0E+5 cells per well	NA	MTS assay	25 MOI	90% cell viability after 24 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3467	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H292	1.0E+5 cells per well	NA	MTS assay	50 MOI	80% cell viability after 24 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3468	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H292	1.0E+5 cells per well	NA	MTS assay	100 MOI	70% cell viability after 24 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3469	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	No	Virus in combination with cisplatin (4 microgram/ml)	No	Cell collection centre china	Human lung cancer cell line	H292	1.0E+5 cells per well	NA	MTS assay	100 MOI	50% cell viability after 24 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3470	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H292	1.0E+5 cells per well	NA	MTS assay	25 MOI	80% cell viability after 48 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3471	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H292	1.0E+5 cells per well	NA	MTS assay	50 MOI	70% cell viability after 48 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3472	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H292	1.0E+5 cells per well	NA	MTS assay	100 MOI	62% cell viability after 48 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3473	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	No	Virus in combination with cisplatin (4 microgram/ml)	No	Cell collection centre china	Human lung cancer cell line	H292	1.0E+5 cells per well	NA	MTS assay	100 MOI	42% cell viability after 48 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3474	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H292	1.0E+5 cells per well	NA	MTS assay	25 MOI	70% cell viability after 72 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3475	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H292	1.0E+5 cells per well	NA	MTS assay	50 MOI	65% cell viability after 72 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3476	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H292	1.0E+5 cells per well	NA	MTS assay	100 MOI	52% cell viability after 72 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3477	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	No	Virus in combination with cisplatin (4 microgram/ml)	No	Cell collection centre china	Human lung cancer cell line	H292	1.0E+5 cells per well	NA	MTS assay	100 MOI	40% cell viability after 72 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3478	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H292	1.0E+5 cells per well	NA	MTS assay	25 MOI	65% cell viability after 96 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3479	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H292	1.0E+5 cells per well	NA	MTS assay	50 MOI	60% cell viability after 96 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3480	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H292	1.0E+5 cells per well	NA	MTS assay	100 MOI	55% cell viability after 96 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3481	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	No	Virus in combination with cisplatin (4 microgram/ml)	No	Cell collection centre china	Human lung cancer cell line	H292	1.0E+5 cells per well	NA	MTS assay	100 MOI	40% cell viability after 96 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3482	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H661	1.0E+5 cells per well	NA	MTS assay	25 MOI	90% cell viability after 24 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3483	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H661	1.0E+5 cells per well	NA	MTS assay	50 MOI	75% cell viability after 24 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3484	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H661	1.0E+5 cells per well	NA	MTS assay	100 MOI	60% cell viability after 24 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3485	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	No	Virus in combination with cisplatin (4 microgram/ml)	No	Cell collection centre china	Human lung cancer cell line	H661	1.0E+5 cells per well	NA	MTS assay	100 MOI	35% cell viability after 24 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3486	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H661	1.0E+5 cells per well	NA	MTS assay	25 MOI	85% cell viability after 48 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3487	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H661	1.0E+5 cells per well	NA	MTS assay	50 MOI	70% cell viability after 48 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3488	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H661	1.0E+5 cells per well	NA	MTS assay	100 MOI	50% cell viability after 48 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3489	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	No	Virus in combination with cisplatin (4 microgram/ml)	No	Cell collection centre china	Human lung cancer cell line	H661	1.0E+5 cells per well	NA	MTS assay	100 MOI	25% cell viability after 48 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3490	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H661	1.0E+5 cells per well	NA	MTS assay	25 MOI	80% cell viability after 72 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3491	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H661	1.0E+5 cells per well	NA	MTS assay	50 MOI	70% cell viability after 72 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3492	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H661	1.0E+5 cells per well	NA	MTS assay	100 MOI	50% cell viability after 72 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3493	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	No	Virus in combination with cisplatin (4 microgram/ml)	No	Cell collection centre china	Human lung cancer cell line	H661	1.0E+5 cells per well	NA	MTS assay	100 MOI	25% cell viability after 72 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3494	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H661	1.0E+5 cells per well	NA	MTS assay	25 MOI	75% cell viability after 96 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3495	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H661	1.0E+5 cells per well	NA	MTS assay	50 MOI	60% cell viability after 96 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3496	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	Yes	No	No	Cell collection centre china	Human lung cancer cell line	H661	1.0E+5 cells per well	NA	MTS assay	100 MOI	45% cell viability after 96 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_3497	Adenovirus	Adenovirus CRAds	DNA	Adenoviridae	None	No	Virus in combination with cisplatin (4 microgram/ml)	No	Cell collection centre china	Human lung cancer cell line	H661	1.0E+5 cells per well	NA	MTS assay	100 MOI	25% cell viability after 96 hours	No	No	NA	No response	NA	NA	NA	NA	28638457
OV_4442	Herpes simplex virus	G47-delta	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN3	4000 to 5000 cells per well	NA	MTS assay	0.03 MOI	78% cell survival after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380
OV_4443	Herpes simplex virus	G47-delta	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN3	4000 to 5000 cells per well	NA	MTS assay	0.1 MOI	18% cell survival after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380
OV_4444	Herpes simplex virus	G47-delta	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN3	4000 to 5000 cells per well	NA	MTS assay	0.3 MOI	1% cell survival after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380
OV_4445	Herpes simplex virus	G47-delta	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN3	4000 to 5000 cells per well	NA	MTS assay	1 MOI	100% cell killing after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380
OV_4446	Herpes simplex virus	G47-delta	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN7	4000 to 5000 cells per well	NA	MTS assay	0.001 MOI	68% cell survival after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380
OV_4447	Herpes simplex virus	G47-delta	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN7	4000 to 5000 cells per well	NA	MTS assay	0.003 MOI	40% cell survival after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380
OV_4448	Herpes simplex virus	G47-delta	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN7	4000 to 5000 cells per well	NA	MTS assay	0.01 MOI	22% cell survival after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380
OV_4449	Herpes simplex virus	G47-delta	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN7	4000 to 5000 cells per well	NA	MTS assay	0.03 MOI	18% cell survival after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380
OV_4450	Herpes simplex virus	G47-delta	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN7	4000 to 5000 cells per well	NA	MTS assay	0.1 MOI	16% cell survival after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380
OV_4451	Herpes simplex virus	G47-delta	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN7	4000 to 5000 cells per well	NA	MTS assay	0.3 MOI	16% cell survival after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380
OV_4452	Herpes simplex virus	G47-delta	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN7	4000 to 5000 cells per well	NA	MTS assay	1 MOI	16% cell survival after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380
OV_4453	Herpes simplex virus	G47-delta-mCherry	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN465	4000 to 5000 cells per well	NA	MTS assay	0.04 MOI	45% cell viablity after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380
OV_4454	Herpes simplex virus	G47-delta-mCherry	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN475	4000 to 5000 cells per well	NA	MTS assay	0.04 MOI	45% cell viablity after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380
OV_4455	Herpes simplex virus	G47-delta-mCherry	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN298	4000 to 5000 cells per well	NA	MTS assay	0.04 MOI	70% cell viablity after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380
OV_4456	Herpes simplex virus	G47-delta-mCherry	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN1	4000 to 5000 cells per well	NA	MTS assay	0.04 MOI	30% cell viablity after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380
OV_4457	Herpes simplex virus	G47-delta-mCherry	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN465	4000 to 5000 cells per well	NA	MTS assay	0.11 MOI	30% cell viablity after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380
OV_4458	Herpes simplex virus	G47-delta-mCherry	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN475	4000 to 5000 cells per well	NA	MTS assay	0.11 MOI	35% cell viablity after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380
OV_4459	Herpes simplex virus	G47-delta-mCherry	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN298	4000 to 5000 cells per well	NA	MTS assay	0.11 MOI	55% cell viablity after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380
OV_4460	Herpes simplex virus	G47-delta-mCherry	DNA	Herpesviridae	Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6	Yes	No	No	Human patient	malignant leningioma	MN1	4000 to 5000 cells per well	NA	MTS assay	0.11 MOI	20% cell viablity after 96 hours	No	No	NA	No response	NA	NA	NA	NA	26951380